0
ResApp Health Limited Banner Image

ResApp Health Limited

  • Ticker RAP
    Exchange ASX More
  • Industry Healthcare Information Services More
  • Sector Healthcare More
ResApp Health Limited Logo Image
  • 11-50 Employees
  • Based in Brisbane, Australia
ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company offers ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department, and primary care markets; and SleepCheck, a smartphone application that allows consumers to self-assess the riskMore of sleep apnoea. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. ResApp Health Limited has a joint development and pilot agreement with Medgate AG to integrate and test smartphone-based acute respiratory diagnostic test. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was incorporated in 2000 and is headquartered in Brisbane, Australia.
ResApp Health Limited

Most Recent Annual Report

ResApp Health Limited
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports